Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On ...

Takeda offers strong cash flow, solid growth in key areas, and a 4.4% yield, but trades at a premium despite its fundamentals ...

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK) shares rose 3.5% following the announcement of encouraging Phase 3 trial results ...

Earnings Call Insights: Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement effective June 2026 after a 12-year tenure. Julie ...

Takeda has partnerships with a number of U.S. pharmaceutical companies, and made headlines in 2018 when it announced plans for a massive acquisition of Shire that was completed about a year ago.

About Takeda Pharmaceutical Company Limited. Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, ...

Takeda Pharmaceutical Company Limited (“Takeda”) and BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Dis ...

Takeda Pharmaceuticals USA, based in Deerfield, Ill., is a wholly owned subsidiary of the Japanese Takeda Pharmaceutical Co. Here are four things to know. 1. Takeda focuses on oncology, ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK ...

Takeda Pharmaceutical Co.45021.52%increase; green up pointing triangle is near a deal worth more than $60 billion to buy European drugmaker Shire PLC, having raised its bid four times in a sign of ...

Takeda Pharmaceutical Co.4502-4.65%decrease; red down pointing triangle on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker and ...